Every 8-K that Adtalem Global Education Inc. (ATGE) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ATGE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ATGE filings page.
Covista Inc. reported third quarter fiscal 2026 results showing steady growth and stronger guidance. Revenue for the quarter was $487.0 million, up 4.5% year over year, with operating income edging up to $91.3 million. Net income from continuing operations was $58.0 million, while a loss from discontinued operations reduced total net income to $41.6 million.
Total students surpassed 100,000, with enrollment up 6.8% year over year and growth in every segment. Chamberlain revenue rose 2.3% with slightly higher operating income, Walden revenue grew 4.6% but with lower operating income, and Medical and Veterinary revenue increased 8.9% with operating income up 18.7%.
For the full fiscal year 2026, Covista raised its revenue outlook to $1,930–$1,945 million, or about 8–9% growth, and lifted adjusted earnings per share guidance to $7.95–$8.15, or roughly 19–22% growth year over year. Adjusted EBITDA for the quarter was $127.9 million, and net leverage stood at 0.7x, supported by strong cash generation and reduced long-term debt.
Covista Inc. furnished an investor newsletter dated April 9, 2026, providing updates on key milestones, strategic developments, and operational progress. The newsletter is attached as Exhibit 99.1 and is incorporated by reference for informational purposes.
The company emphasizes that the newsletter and related information under Regulation FD are furnished, not filed, so they are not subject to certain Exchange Act liabilities and are not automatically incorporated into other securities law filings. Covista also includes standard cautionary language that the newsletter contains forward-looking statements subject to risks described in its most recent Form 10-K and other SEC filings.
Covista Inc. entered into an Amendment No. 5 to its Credit Agreement on March 2, 2026, creating new 2026 Term Loans with an aggregate original principal of $510 million maturing on March 2, 2033. These loans bear interest at Term SOFR plus 2.25% (with a 0.75% SOFR floor) or an alternate base rate plus 1.25%, and the amendment reduced term loan interest margins by 0.50%.
The company used the 2026 Term Loan proceeds to fully refinance existing term loans under the prior credit agreement and to redeem in full its 5.50% Senior Secured Notes due 2028. The redemption covered approximately $404,950,000 of principal at 100% of par plus accrued interest, after which the related indenture was fully satisfied and discharged.
Covista Inc. is using its Investor Day to lay out a new three-year growth strategy, called Purpose at Scale, focused on expanding its healthcare education platform and addressing the U.S. healthcare workforce shortage. The company now serves more than 97,000 students and has graduated 24,000 healthcare professionals in the last year, including 10% of America's nurses. Covista is reaffirming its fiscal 2026 outlook and introducing long-term targets for fiscal 2027–2029, aiming for annual revenue growth of 6–8%, 7–10% and 8–11%, and adjusted earnings per share growth of 9–13%, 10–14% and 12–16%, respectively. Management also highlights disciplined capital allocation, potential M&A and share repurchases, and notes that its stock will begin trading under the new ticker CVSA on the NYSE.
Covista Inc., formerly Adtalem Global Education Inc., has officially changed its corporate name and updated its governing documents to reflect the new identity as of February 5, 2026. The company’s common stock will begin trading on the New York Stock Exchange under the ticker symbol CVSA on February 24, 2026, with existing stock certificates remaining valid.
The company is positioning itself as America’s largest healthcare educator, operating five accredited institutions that serve more than 97,000 students and a network of 385,000 alumni. Covista reports graduating about 24,000 healthcare professionals each year, including 10% of America’s nurses, and educating twice as many MDs as any MD-granting school in the U.S., as well as being the leading provider of Doctors of Veterinary Medicine to the U.S.
Covista also introduced the Covista Care Capacity Monitor, a research platform developed with Gallup to analyze healthcare workforce shortages across states and disciplines, and announced an Investor Day on February 24, 2026 to present its long-term strategic plan and investment priorities. In addition, Covista and The Covista Foundation launched the multi-year “Covista Open Doors” commitment to expand healthcare career pathways, support students through financial and mentoring programs, and address healthcare worker wellbeing.
Adtalem Global Education Inc. filed a current report to note it has released its second quarter fiscal 2026 academic, operating and financial results. The company states these results in a separate press release dated January 28, 2026, which is attached as an exhibit.
The filing also includes a standard caution that certain statements about future growth and other expectations are forward-looking and subject to risks and uncertainties, referring readers to the company’s most recent annual report and other SEC filings for detailed risk factors.
Adtalem Global Education Inc. reported that its Board of Directors has authorized the repurchase of up to an additional $750 million of its common stock. The company may buy shares over time through open market purchases, accelerated share repurchases, privately negotiated deals or other methods, in line with Rule 10b-18 and subject to market conditions, through the period ending December 15, 2028.
Adtalem also announced that it has completed its prior share repurchase program, under which it repurchased $150 million of its shares. The company noted that the new authorization does not require it to repurchase a specific number of shares and can be suspended, modified or terminated at any time without prior notice.
Adtalem Global Education reported final results from its Annual Meeting of Shareholders held on November 12, 2025. Shareholders voted on director nominees and other proposals, with detailed tallies disclosed.
For director nominees, “For” votes ranged from 30,915,164 (Stephen W. Beard) to 31,742,972 (Kenneth J. Phelan). Each nominee’s “Against” votes were under 820,000, with broker non‑votes of 1,443,088 recorded for all director items.
Additional proposals received the following totals: 32,536,515 For, 627,124 Against, and 78,017 Abstain; and 27,143,411 For, 4,326,428 Against, 328,729 Abstain, with 1,443,088 broker non‑votes.
Adtalem Global Education Inc. (ATGE) furnished an 8‑K announcing that it issued a press release with its first quarter fiscal 2026 academic, operating, and financial results. The press release is attached as Exhibit 99.1 and incorporated by reference.
The company states this information is provided under Item 2.02 and is furnished, not filed under the Exchange Act. The filing includes a customary caution about forward‑looking statements referencing risk factors in its most recent 10‑K.
Adtalem Global Education, Inc. reported a leadership change at Chamberlain University following the retirement of Dr. Cox after a distinguished, nearly 40-year career in healthcare and nursing education. Dr. Cox led Chamberlain since 2018, during which the institution expanded to serve nearly 40,000 students online and across 24 physical campuses and became the largest school of nursing in the U.S. and the leading grantor of Bachelor of Science in Nursing degrees. The filing frames this as a material event related to leadership transition; financial results, transactions, and other operational details were not disclosed in the provided excerpt.